powerpoint presentation - lecture...
TRANSCRIPT
Macrolides
Erythromycin, Azithromycin
Clarithromycin
• it contain Macrocyclin lacton .
• Erythromycin used as alternative to penicillin in patient
with allergic to penicillin.
- Low to mild dose = bacteriostatic
- high doses = bactericidal
MECHANISMS OF ACTION OF
ANTIBACTERIAL DRUGS
Macrolids Reversibly binds to 50S.
Macrolide inhibit bacterial protein synthesis by binding reversibly to 50S ribosomal subunit and inhibit RNA dependent protein synthesis. Prevents continuation of
protein synthesis.
It consider bacterostatic and may be cidal at high dose
Erythromycin • Erythromycin :effective against many of the same
MO as Penicillin group so used as an alternative
- Absorption:
• incompletely but adequately absorbed from intestine
- inactivated by gastric acid , so it is given as enteric coated tab. or as cap.
- food impair absorption.
- Higher concentration can be achieved by I.V administration
• Distribution
-diffuse into intracellular fluids , not enter CSF & brain
-protein binding is 70-80%
-cross placenta and milk
• Elimination
.erythromycin : t1\2 is 1.6 hr
-metabolized by liver and excreted by bile, urine .
• Dosage
1-2 gm\day in divided dose i.e 6 hourly
30-50 mg\ Kg\ day for children (can be doubled in sever infection)
Clarithromycin
-absorbed rapidly from GIT
-hepatic first pass metabolism reduces bioavailability to 50%
-can be given with or without food
-peak conc. Occurs 2hr after administration
-have higher intracellular conc.
-protein binding is 40-70%.
-more active against Gram (+) pathogens, than Erythromycin
Elimination :
- t 1\2: 3-7 hr
- Excreted by urine
- Dosage : 250 mg \twice daily (double in sever infection)
7.5 mg\Kg\twice daily for children
Azithromycin
- more active than erythromycin against several Gram (-)
pathogens
- Given orally , absorbed rapidly.
- 50% protein binding.
- Distributed widely (except brain ,CSF)
- Should not be given with food (Should be administered 1
hour before or 2 hours after meals; aluminum and
magnesium delay absorption and reduce peak serum
concentrations
- Can be given I.V
- extensive tissue distribution and high drug conc. Within
cells (maintains high concentrations for prolonged periods
into a number of tissues (lungs, tonsil, cervix))
• Elimination
--mainly by liver
-12% by urine
- long half-life allows once daily oral
administration and shortening of treatment in
many cases
-Does not inactivate cytochrome p450 enzymes
and free of the drug interactions that occur
with erythromycin and clarithromycin
Therapeutic uses of macrolides
• Drug of choice for mycoplasma pneumonia
• Chlamydial infection
• Diphtheria
• Syphilis
• Streptococcal (alternative to P)
• Staphylococcal
Adverse effect macrolides
1- large dose cause epigastic pain , increase GIT motility
2- ototoxicity : transient deafness
3-Contraindication in patient with hepatic dysfunction
4- drug interaction : its enzyme inhibitor so it inhibit
metabolism of number drugs which lead to toxic
accumulation of drug like Warfarin
Therapeutic uses in
dentistry • Erythromycin has a long and successful history of
use against acute orofacial infections, particularly
in β-lactam–allergic patients.
• Its spectrum of activity is good to excellent
against gram-positive aerobic/facultative cocci
(streptococci, somestaphylococci).
Cont.
• Azithromycin has been observed to be effective
against oral spirochetes and pigmented anaerobes.
In the management of acute periapical abscesses,
azithromycin,500 mg/day for 3 days, has shown
comparable efficacy to amoxicillin/clavulanic
acid, 625 mg three times daily for 5 to 10 days.
• Macrolides are also useful for endocarditis
prophylaxis.
Cont.
• Clarithromycin is most active against gram-
positive anaerobes (Actinomyces,
Propionibacterium, Lactobacillus),
• whereas erythromycin is more active than
azithromycin for these organisms.
• Azithromycin has the best activity against gram-
negative anaerobes (Fusobacterium, Prevotella,
Porphyromonas,